Ripretinib is a kinase inhibitor used as a pharmaceutical raw material for the manufacturing of advanced gastrointestinal stromal tumor (GIST) therapy. It is indicated for cases that have not adequately responded to other kinase inhibitors such as sunitinib and imatinib.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ripretinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
3-[[4-[methyl-[2-(4-methyl-1-piperazinyl)-1-oxoethyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylic acid methyl ester
pharmaceutical raw material
2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-7-oxido-9H-purin-9-yl]-, (1S,4R)-
pharmaceutical raw material
Landiolol hydrochloride
pharmaceutical raw material
Carbovir Monophosphate
pharmaceutical raw material
Tirofiban
pharmaceutical raw material
The international HS code for Ripretinib (CAS 1442472-39-0) is 2933.79.
2933.79
2933 79 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea
CEFJVGZHQAGLHS-UHFFFAOYSA-N
CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC
Sourcing Ripretinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.